Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 26, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for March 12, 2007 Subscribe to this News Feed      
 

Have Scientists Accidentally Discovered The Cure For Hair loss?

Their discovery was made while applying a synthetically formulated compound, Copper Peptide, to severe wound areas on several patients.

Simi Valley, CA (PRWEB) March 12, 2007 -- Research scientists may have stumbled onto the answer to something that has frustrated mankind for centuries. Their discovery was made while applying a synthetically formulated compound, Copper Peptide, to severe wound areas on several patients. During this process something unusual happened. Not only did the wounds heal about 30 percent faster, but a significant stimulation of the follicular cells occurred. As a side effect, these tripeptide complexes actually grew hair around the wound area.

The discovery was so startling that they then applied the same Copper Peptide complex to a female patient who had suffered roughly 90 percent alopecia or, hair loss, for years. After about six months of use, she had recovered almost 100 percent of her hair.

Tests were then conducted with chemotherapy patients and recent hair transplant recipients, all with great success in stimulating newer and stronger hair follicles. The implications of such a startling discovery have gotten the attention of several large companies. Neutrogena, Johnson & Johnson, Procter & Gamble, and Dow Chemical are just a few of the big companies that have shown interest in the peptides.

The discovery could have major implications in the somewhat shady area of the hair growth industry. There are many products that promise amazing results but they usually fail to deliver. Most have some sort of DHT inhibitor with traces of Minoxidil so they can claim Food and Drug Administration (FDA) approval. There is one company that has been able to take advantage of this and manufacture for the public. Everest R & D Labs, located in California's Simi Valley.

Incredible advancements in the manufacturing process of Copper Peptide technology are bringing even better results in hair re-growth than the original tests. Some people providing the company with feedback are offering amazing stories, with positive side effects that include the reduction of acne and psoriasis. There have been many reports from both men and women. Reports from women include statements that their graying hair is regaining some of its original pigmentation.

This product has been integrated into a therapeutic shampoo and conditioner called Follipro. As more and more corroborating evidence from research universities around the country become available, the possibilities for this new technology could be far-reaching.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/TWFnbi1TaW5nLVpldGEtU3VtbS1NYWduLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Jeff Yeomans
Everest R&D Labs INC.
800-426-8849
Email us Here
ATTACHED FILES

The possibilities for this new technology could be far-reaching.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright